Covered by insurance in all 50 states, incl. Medicare Advantage day one
Back to Blog

Pristiq vs Lexapro: SNRI or SSRI First?

Last updated November 4, 2026

Key Takeaways

  • Pristiq (desvenlafaxine) is an SNRI that raises serotonin and norepinephrine. Lexapro (escitalopram) is an SSRI that targets serotonin. Both are FDA approved for depression, and only Lexapro is also approved for generalized anxiety disorder.
  • In the one large head-to-head trial, in postmenopausal women with depression, the two worked about equally well and were similarly tolerated.
  • Pristiq has very few liver-enzyme interactions, which can matter if you take several other medications. It can raise blood pressure, so regular blood pressure checks are part of the plan.
  • Lexapro is often chosen first because large reviews rank it among the better tolerated antidepressants, and it covers anxiety too. The right first pick depends on your symptoms, other medications, and health history.

Most comparisons of Pristiq and Lexapro ask which one is stronger. That question misses what actually decides the first pick.

Your mood, energy, and stress response all run on chemical messengers passing between nerve cells. Antidepressants work by keeping more of those messengers available, and they differ mainly in which ones they target. Lexapro (escitalopram) aims with precision at serotonin, while Pristiq (desvenlafaxine) acts on both serotonin and norepinephrine. That difference in mechanism shapes side effects, interactions, and who each drug suits, more than it shapes how well either one works.

The long-standing standard of care is to start with a well-studied antidepressant, give it a fair trial, and adjust based on response. It works. A 2018 network meta-analysis of 522 trials and more than 116,000 adults found every antidepressant studied beat placebo for depression, and in head-to-head trials escitalopram was among the more effective and better tolerated options. The results are real, and the science is well established.

But a first prescription is only as good as the follow-up that comes after it, and at Siggy we don’t believe a medication choice should end at the pharmacy counter.

This guide compares Pristiq and Lexapro on what the evidence actually shows, so you can walk into the conversation with your prescriber knowing which questions matter for your situation, because the right first choice is a clinical decision rooted in your history and your own biology.

What This Page Covers

What Are Pristiq and Lexapro?

Lexapro is an SSRI, or selective serotonin reuptake inhibitor. In plain terms, it slows how quickly nerve cells reabsorb serotonin, so more stays active. According to escitalopram’s FDA label, it is approved for major depressive disorder in adults and teens 12 and older, and for generalized anxiety disorder.

Pristiq is an SNRI, or serotonin and norepinephrine reuptake inhibitor. It is the major active metabolite of venlafaxine (Effexor), taken as an extended-release tablet. The FDA label for desvenlafaxine lists one approved use: major depressive disorder in adults.

If you want a deeper look at either drug alone, see our guides to Pristiq for depression and Lexapro for anxiety.

How Do Pristiq and Lexapro Compare Side by Side?

The FDA labels for both medications describe these core differences:

Feature Pristiq (Desvenlafaxine) Lexapro (Escitalopram)
Drug class SNRI SSRI
FDA-approved uses Depression in adults Depression (age 12+), generalized anxiety
Usual dose 50 mg once daily 10 mg once daily, up to 20 mg
Benefit above usual dose None shown above 50 mg None shown at 20 mg vs 10 mg in one trial
Main processing route Conjugation, kidneys Liver enzymes CYP3A4 and CYP2C19
Blood pressure Monitor regularly No clinically important changes in trials
Tablet handling Swallow whole, never split 10 and 20 mg tablets scored

Both labels carry the same boxed warning about suicidal thoughts in children, teens, and young adults, and both advise tapering rather than stopping suddenly.

Does One Work Better Than the Other?

For most people, the honest answer is that neither has a proven edge. The largest direct comparison is a randomized double-blind trial in postmenopausal women aged 40 to 70 with major depression. After eight weeks, depression scores dropped by similar amounts on desvenlafaxine and escitalopram. Over six more months, 82% of women on desvenlafaxine and 80% on escitalopram kept their response, a difference that was not statistically meaningful.

That trial was designed to test whether an SNRI would outperform an SSRI in this group, and it did not. The study’s limits matter too: it included only postmenopausal women, so results may not apply to everyone.

Guidelines reflect this. The CANMAT 2023 depression guidelines list 17 first-line antidepressants and say the first choice can be any of them, based on efficacy, side effects, clinical presentation, cost, and patient preference. They also emphasize shared decision-making, which means your values and history should shape the choice alongside the data.

How Do the Side Effects Differ?

Nausea is the most common early side effect of both. In the FDA labels’ placebo-controlled trials, nausea affected 22% of people on Pristiq 50 mg compared with 10% on placebo, and 15% of people on Lexapro for depression compared with 7% on placebo. For many people it fades in the first weeks.

A few differences are worth knowing:

  • Blood pressure: Pristiq’s label calls for regular blood pressure checks. In short-term studies, sustained high diastolic pressure occurred in 1.3% of people on 50 mg versus 0.5% on placebo.
  • Sweating: excess sweating was reported in 10% on Pristiq 50 mg versus 4% on placebo.
  • Sexual side effects: both labels list decreased libido and delayed orgasm or ejaculation. These are often underreported, so tell your prescriber if they show up.
  • Heart rhythm: Lexapro’s label reports a small average QTc change of about 4.5 milliseconds at 10 mg, which matters mainly for people with other heart rhythm risks.

Our guide to Lexapro side effects covers what tends to ease and what is worth reporting.

Which Has Fewer Drug Interactions?

This is where Pristiq has a real practical advantage. Its label states it is processed mostly by conjugation, a pathway that does not depend on the CYP2D6 liver enzyme, and about 45% leaves the body unchanged in urine. A drug interaction review classed both desvenlafaxine and escitalopram as weak or non-inhibitors of liver enzymes at usual doses, unlike duloxetine and bupropion.

Lexapro is broken down by two liver enzymes, CYP3A4 and CYP2C19, and has a modest effect on CYP2D6. That is usually manageable, but it is one more thing for your prescriber to check if you take heart, pain, or other psychiatric medications.

Both drugs share two interaction warnings: a higher risk of serotonin syndrome with other serotonergic drugs, and a higher bleeding risk when combined with NSAIDs like ibuprofen, aspirin, or blood thinners.

When Might a Prescriber Choose an SNRI First?

Lexapro is often a first pick because it covers both depression and anxiety and has a strong tolerability record. A prescriber might lean toward Pristiq when:

  • You take several medications and interaction risk is a concern
  • You already tried an SSRI that did not help enough

On the second point, the evidence is limited. In an open-label extension study, postmenopausal women who did not respond to escitalopram showed continued improvement after switching to desvenlafaxine, though the study had no comparison group.

Pristiq may be a less natural fit if you have uncontrolled high blood pressure or significant kidney disease, which requires a lower maximum dose. If anxiety is your main concern, Lexapro’s FDA approval for generalized anxiety is often decisive.

What Happens After You Start?

The first few weeks are when most people decide whether to keep going. In a national antidepressant study, 42.4% of adults starting treatment for depression stopped within the first 30 days. That early window is when side effects peak and questions pile up, and it’s often when people feel most on their own.

Whichever you start, ask your prescriber how long to wait before judging the result, which side effects should prompt a call, and how a dose change or switch would work. Never stop either medication abruptly. Our guide to Pristiq withdrawal explains why tapering matters.

If you ever have thoughts of harming yourself, call 911 or call or text 988 right away.

How Siggy Fits In

Siggy starts with a free, anonymous intake. No name, email, or account is needed. You describe your symptoms, history, and the medications you already take, at your own pace. The intake is preclinical and does not diagnose you on its own.

A licensed prescriber reviews your answers before anything is recommended, including your history, a standard depression questionnaire, and more than one possible explanation for your symptoms. Siggy’s prescribers treat the full range of mental health conditions, and every treatment plan is approved by a real clinician. You also get a downloadable summary you can share with any doctor.

After you start, Siggy’s AI provides therapy between visits, and what you share helps your care team see how treatment is actually going.

This article is for education and is not a substitute for advice from your own clinician. It reflects sources available as of November 2026.

Start Your Anonymous Intake

Pristiq and Lexapro work about equally well for depression in the best head-to-head evidence. The real differences are practical: Lexapro also treats generalized anxiety and has a strong tolerability record, while Pristiq has fewer liver-enzyme interactions but needs blood pressure monitoring. The best first choice depends on your symptoms, your other medications, and what has or hasn’t worked before. If you’re also weighing other SSRIs, our comparison of Lexapro vs Zoloft is a helpful next read.

You don’t have to figure this out alone. Start your anonymous intake with Siggy. It’s free, no name or email is required, and a real clinician reviews everything before any treatment is recommended.

Mental healthcare should stay with you between appointments.

Siggy combines daily check-ins with clinician-supervised care so your treatment plan can respond to what is actually happening.

Start anonymously. A real doctor reviews every clinical decision. HIPAA-compliant.

Start Anonymous Intake

Frequently Asked Questions

Is Pristiq stronger than Lexapro?

No, Pristiq is not clearly stronger than Lexapro. In a randomized, double-blind trial of postmenopausal women with major depression, desvenlafaxine (Pristiq) and escitalopram (Lexapro) reduced depression scores by similar amounts, and the share of women who stayed well over six months was nearly identical (82% vs 80%). Acting on two neurotransmitters does not automatically make a medication more effective for any one person.

Should I try an SNRI or an SSRI first for depression?

Either can be a reasonable first choice. Canadian depression guidelines list 17 first-line antidepressants and say the first pick can be any of them, weighing efficacy, side effects, your symptoms, cost, and your preferences. SSRIs like Lexapro are often tried first because of their tolerability record, while an SNRI like Pristiq may suit people who take several other medications or who did not respond to an SSRI.

Can Pristiq or Lexapro treat anxiety?

Lexapro is FDA approved to treat generalized anxiety disorder as well as depression. Pristiq is FDA approved only for major depressive disorder in adults. If anxiety is a main symptom, that difference often shapes which medication a prescriber suggests first.

Can you switch from Lexapro to Pristiq?

Yes, switching between the two is common, but it should be planned with your prescriber. The Pristiq label notes that discontinuation symptoms have been reported when switching from other antidepressants and that tapering the first medication may be needed. Do not stop or swap either medication on your own.

Does Pristiq raise blood pressure?

It can. The FDA label for desvenlafaxine says blood pressure increases were seen in clinical studies, recommends controlling high blood pressure before starting, and advises regular blood pressure monitoring during treatment. Sustained high diastolic blood pressure occurred in about 1.3% of people on 50 mg compared with 0.5% on placebo in short-term studies.

What is the usual dose of Pristiq and Lexapro?

Pristiq is usually taken at 50 mg once daily, which the FDA label describes as both the starting and the therapeutic dose, since higher doses showed no added benefit in trials. Lexapro usually starts at 10 mg once daily and can be increased to a maximum of 20 mg after at least a week if needed.

Sources

  1. Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018;391(10128):1357-1366. doi:10.1016/S0140-6736(17)32802-7
  2. Escitalopram oxalate tablets prescribing information. DailyMed, U.S. National Library of Medicine. DailyMed label
  3. Desvenlafaxine extended-release tablets prescribing information. DailyMed, U.S. National Library of Medicine. DailyMed label
  4. Soares CN, Thase ME, Clayton A, et al. Desvenlafaxine and escitalopram for the treatment of postmenopausal women with major depressive disorder. Menopause. 2010;17(4):700-711. doi:10.1097/gme.0b013e3181d88962
  5. Lam RW, Kennedy SH, Adams C, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 update on clinical guidelines for management of major depressive disorder in adults. Canadian Journal of Psychiatry. 2024;69(9):641-687. doi:10.1177/07067437241245384
  6. Spina E, Trifirò G, Caraci F. Clinically significant drug interactions with newer antidepressants. CNS Drugs. 2012;26(1):39-67. doi:10.2165/11594710-000000000-00000
  7. Soares CN, Thase ME, Clayton A, et al. Open-label treatment with desvenlafaxine in postmenopausal women with major depressive disorder not responding to acute treatment with desvenlafaxine or escitalopram. CNS Drugs. 2011;25(3):227-238. doi:10.2165/11586460-000000000-00000
  8. Olfson M, Marcus SC, Tedeschi M, Wan GJ. Continuity of antidepressant treatment for adults with depression in the United States. American Journal of Psychiatry. 2006;163(1):101-108. doi:10.1176/appi.ajp.163.1.101